GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascelia Pharma AB (OSTO:ACE) » Definitions » Other Stockholders Equity

Ascelia Pharma AB (OSTO:ACE) Other Stockholders Equity : kr0.65 Mil (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Ascelia Pharma AB Other Stockholders Equity?

Ascelia Pharma AB's Other Stockholders Equity for the quarter that ended in Sep. 2024 was kr0.65 Mil.

Ascelia Pharma AB's quarterly Other Stockholders Equity increased from Mar. 2024 (kr0.61 Mil) to Jun. 2024 (kr0.62 Mil) and increased from Jun. 2024 (kr0.62 Mil) to Sep. 2024 (kr0.65 Mil).

Ascelia Pharma AB's annual Other Stockholders Equity increased from Dec. 2021 (kr0.25 Mil) to Dec. 2022 (kr0.97 Mil) but then declined from Dec. 2022 (kr0.97 Mil) to Dec. 2023 (kr0.67 Mil).


Ascelia Pharma AB Other Stockholders Equity Historical Data

The historical data trend for Ascelia Pharma AB's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascelia Pharma AB Other Stockholders Equity Chart

Ascelia Pharma AB Annual Data
Trend Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial - 0.12 0.25 0.97 0.67

Ascelia Pharma AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.67 0.61 0.62 0.65

Ascelia Pharma AB Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Ascelia Pharma AB Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Ascelia Pharma AB's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascelia Pharma AB Business Description

Traded in Other Exchanges
N/A
Address
Hyllie Boulevard 34, Malmo, SWE, SE-215 32
Ascelia Pharma AB is an oncology-dedicated drug development company located in Malmo Sweden focused on orphan oncology It develops and commercializes novel drugs that address unmet medical needs and have a clear development and market pathway The company has two drug candidates Orviglance and Oncoral in clinical development.

Ascelia Pharma AB Headlines

No Headlines